Protective effect of ursodeoxycholic acid on COVID-19 in patients with chronic liver disease
ObjectiveUrsodeoxycholic acid (UDCA) may reduce susceptibility to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection by downregulating angiotensin-converting enzyme 2 (ACE2), based on recent experimental investigation. This study aimed to determine the potential protective effect...
Main Authors: | Yanyan Li, Na Zhu, Xinyu Cui, Yingying Lin, Xin Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-05-01
|
Series: | Frontiers in Cellular and Infection Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcimb.2023.1178590/full |
Similar Items
-
Corticosteroid therapy for coronavirus disease 2019-related acute respiratory distress syndrome: a cohort study with propensity score analysis
by: Chaomin Wu, et al.
Published: (2020-11-01) -
Comparison of clinical characteristics and hospital mortality in critically ill patients without COVID-19 before and during the COVID-19 pandemic: a multicenter, retrospective, propensity score-matched study
by: Sua Kim, et al.
Published: (2022-06-01) -
Elevated hyaluronic acid levels in severe SARS-CoV-2 infection in the post-COVID-19 era
by: Yanyan Li, et al.
Published: (2024-02-01) -
Drug-Induced Liver Disturbance During the Treatment of COVID-19
by: Guanghua Zhai, et al.
Published: (2021-08-01) -
Impact of Co-morbidities on Outcome of COVID-19 Patients: An Observational Study among Patients Admitted to Intensive Care Unit
by: Hemant Kumar, et al.
Published: (2021-07-01)